Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 30, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

What is the patent landscape for Protamine Sulfate, and what generic Protamine Sulfate alternatives are available?

Protamine Sulfate is a drug marketed by Pharmacia And Upjohn, Fresenius Kabi Usa, Lilly, and West-ward Pharms Int. and is included in five NDAs.

The generic ingredient in PROTAMINE SULFATE is protamine sulfate. There are twelve drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the protamine sulfate profile page.

Summary for Tradename: PROTAMINE SULFATE

Suppliers / Packagers: see list2
Clinical Trials: see list304
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PROTAMINE SULFATE at DailyMed

Pharmacology for Tradename: PROTAMINE SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
protamine sulfate
INJECTABLE;INJECTION007413-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
protamine sulfate
INJECTABLE;INJECTION006460-002Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
Pharmacia And Upjohn
protamine sulfate
INJECTABLE;INJECTION007413-002Aug 2, 1984DISCNNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
protamine sulfate
INJECTABLE;INJECTION089454-001Apr 7, 1987RXNoYes► Subscribe► Subscribe
West-ward Pharms Int
protamine sulfate
INJECTABLE;INJECTION089475-001Nov 5, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Formulary management
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus